Department of Ophthalmology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
Department of Ophthalmology, Taipei Municipal Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan.
Eur J Ophthalmol. 2021 Jul;31(4):1862-1869. doi: 10.1177/1120672120940198. Epub 2020 Jul 6.
To conduct a systematic review and meta-analysis to explore the association between IL-6 gene polymorphisms ( and ) and glaucoma.
A comprehensive search was performed to select eligible studies regarding IL-6 polymorphisms and glaucoma. The effect sizes in the fixed-effects model were calculated using odds ratios (ORs) with 95% confidence intervals (CIs).
Four eligible studies comprising 762 cases and 799 controls were selected for meta-analysis. Regarding the association between the IL-6 polymorphism and glaucoma, those who carried the G/G+G/C genotypes had a non-significant higher risk of glaucoma (OR = 1.29, 95% CI = 0.76-2.19) in the dominant model. However, no obvious association (OR = 0.97, 95% CI = 0.68-1.37) was found for the recessive model (G/G vs G/C+C/C). In the subgroup analysis stratified by ethnicity, no significant associations were observed in populations of Asian or European heritage. Significantly higher glaucoma risks of 15.9 and 99.0 were observed for the dominant (C/C+C/T vs T/T) and recessive (C/C vs C/T+T/T) models, respectively.
No statistically significant glaucoma risks were observed for the except polymorphism of IL-6. Further studies with a larger sample size are required to validate the effects of IL-6 polymorphisms on glaucoma risk.
系统回顾和荟萃分析探讨白细胞介素 6 基因多态性(和)与青光眼的关系。
全面检索以选择关于白细胞介素 6 多态性与青光眼的合格研究。使用固定效应模型计算优势比(OR)及其 95%置信区间(CI)来计算效应大小。
四项合格的研究共纳入 762 例病例和 799 例对照,进行荟萃分析。对于 IL-6 多态性与青光眼之间的关联,在显性模型中,携带 G/G+G/C 基因型的人患青光眼的风险非显著升高(OR=1.29,95%CI=0.76-2.19)。然而,在隐性模型(G/G 与 G/C+C/C)中未发现明显的相关性(OR=0.97,95%CI=0.68-1.37)。按种族进行亚组分析时,在亚洲或欧洲血统的人群中未观察到明显的相关性。显性模型(C/C+C/T 与 T/T)和隐性模型(C/C 与 C/T+T/T)中,青光眼的风险分别显著升高 15.9 和 99.0。
白细胞介素 6 基因的除以外的多态性与青光眼的风险无统计学显著相关性。需要进一步进行更大样本量的研究,以验证白细胞介素 6 多态性对青光眼风险的影响。